<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03314077</url>
  </required_header>
  <id_info>
    <org_study_id>TongjiHospitalResp.</org_study_id>
    <nct_id>NCT03314077</nct_id>
  </id_info>
  <brief_title>Quality Control and Evaluation in Standard COPD Management</brief_title>
  <official_title>Quality Control and Evaluation in Standard COPD Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Affiliated hospital of Guilin medical university,China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University hospital of Hubei university for nationalities,China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>TongjiChibi hospital,China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central health center in Yongjiahe Town,China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinses PLA general hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the second Xiangya hospital of Central sounth university</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the fourth affiliated hospital, Zhejiang university school of medcine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Hospital of China Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huashan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yiwu Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Xuhui Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sijing hospital of Songjiang District in Shanghai</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Youxian People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tong Ren hospital Shanghai Jiao Tong university school of medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhejiang Putuo Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jing-An District Center Hospital of Shanghai (Huashan Hospital Fudan University Jing-An Branch), Shanghai Medical College, Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is lack of quality control and evaluation indexes for standard COPD management in
      hospitals in China, leading to nonstandard in COPD management and discrepancy in therapeutic
      efficiency. This study focuses on establishing quality control and evaluation indexes for
      standard COPD management in hospitals in China, and evaluating the therapeutic efficiency
      after standard COPD management. This part is a prospective cohort which lasts 2 years. After
      standard COPD management according to GOLD 2017 by doctors in hospitals in China, patients
      will be followed up for their outcome after 1 year. Several indexes will be selected to
      evaluate the quality control of standard COPD management and its efficiency. The controls are
      from hospital-based subjects with a retrospective cohort study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in spirometry</measure>
    <time_frame>1 years</time_frame>
    <description>Spirometry will be assessed at baseline and through study completion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity of acute exacerbation in 1 years</measure>
    <time_frame>1 year</time_frame>
    <description>Morbidity of acute exacerbation completion will be assessed at baseline and through study</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">210</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Standard managed subjects</arm_group_label>
    <description>COPD patients accepted standard COPD management.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>COPD patients didn't accepted standard COPD management or quality control, who are from hospital subjects with a retrospective cohort study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>GOLD 2017</intervention_name>
    <description>Standard COPD management according to GOLD 2017, and control the quality of management in one-year follow-up.</description>
    <arm_group_label>Standard managed subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Clinic-based population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1.Clinical manifestation of COPD; post bronchodilator FEV1/FVC&lt;0.70

        Exclusion Criteria:

          -  1. lung cancer. 2. Any history of psychiatric disorders. 3.HIV positive.
             4.Breastfeeding, pregnancy or planning to be pregnant. 5.Estimated lifetime less than
             1 years due to underlying diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>TongjiChibi hospital</name>
      <address>
        <city>Chibi</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tongji hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 15, 2017</study_first_submitted>
  <study_first_submitted_qc>October 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2017</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Weining Xiong</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

